The link between your nutrition and your mental health

The link between your nutrition and your mental health

Our nutritional health affects almost every process in the human body.

And nutrition gives us energy.  A body without food is like a car without fuel, and we certainly wouldn’t put bad fuel in our car. Just like a car, consistently putting bad fuel into our bodies can have a detrimental effect.

For example, if you are a vegetarian, you may not have enough iron in your diet, or if you exclude dairy from your diet, you may not have enough calcium. Such insufficiency is well known for causing various health problems such as anaemia and brittle bones.

But what you may not know is that a lack of particular vitamins or minerals in our diet may also negatively affect our mental health. And it’s not surprising when you learn that the brain and the gastrointestinal systems are so closely linked.

Have you ever had “butterflies in your stomach”? Or been in a “gut-wrenching” situation? These phrases are used for a reason.

Your gastrointestinal system is sensitive to emotion – so whether you feel angry, sad, anxious or excited, this emotion may appear as symptoms in your stomach. The brain can even trigger the release of stomach juices just by thinking about your next meal.

And the connection can work both ways, as the gut-brain relationship is bidirectional. A troubled digestive system can send signals of pain or discomfort to the brain, and can therefore be the cause of mental illbeing.

Low levels of B-12 and other B vitamins such as vitamin B-6 and folate in particular are linked to depression. And this is because they play a role in producing brain chemicals that affect mood and other brain functions. 

It’s therefore important to monitor whether nutritionally you are getting enough of these vitamins in your diet, which may in fact by the source of your mental illbeing. Our scientists at Randox Health thoroughly analyse up to 350 of your body’s biological markers to reveal what’s happening in your body, and if it turns out that a gut imbalance is having an effect on your mental health, there’s something you can do about it.

Determining the appropriate treatment may be as simple as eating more eggs, milk, cheese, milk products, meat, fish, shellfish or poultry, which are known sources of Vitamin B12.

So take control of your health – find out if your stomach problems are contributing to your mental concerns.

Contact the Randox Health team today.

Tel: 0800 2545 130

Email:info@randoxhealthni.com

 

 

 

 


Randox Biosciences exhibit diagnostic innovations at UK-China Oncology Congress

Leading diagnostics firm Randox Laboratories has this week sent a delegation of scientists from its Biosciences Division to take part in the UK Exhibition of Oncology Excellence, between 25th and 29th June in Beijing and Guangzhou, in China.

The centrepiece of the UK-China Oncology Congress, the exhibition has been carefully curated to follow the “Science to Patient Pathway” for new therapies – from research to clinical trials, regulatory approval, manufacturing and distribution.

The Randox Biosciences team, over the course of the Congress event, will join a range of cancer-related seminars, offering an opportunity to learn about and influence Chinese government policies and priorities, and explore the latest trends and hot topics in oncology.

Julie-Ann O’Hare, Sales and Marketing Director for Randox Biosciences, commented;

“At Randox Biosciences we are actively seeking opportunities to strengthen business ties between the UK and China, and of course to showcase our innovative diagnostic capabilities to what is one of our most important and growing markets.

“We continue to expand our business presence there thanks to the ongoing pipeline of novel tests being produced from our innovative research and development programmes and enhanced manufacturing capabilities, including new facilities at the Randox Science Park in Northern Ireland.”

Exhibiting to a diverse audience of universities, hospitals, and laboratories responsible for prevention, diagnosis, treatment and care in oncology, Randox Biosciences have joined the exhibition to showcase their innovative diagnostic tests for bladder cancer and early detection of renal toxicity – including Chronic Kidney Disease and Acute Kidney Injury.

Julie-Ann continued;

“We continue to offer an increasing range of innovative diagnostic biomarkers to the growing and dynamic biotechnology markets.

“The focus on the importance of scientific research in the patient pathway, in enabling cancer diagnoses as soon as possible, offers us the perfect platform to introduce to China our latest pioneering oncological tests, including our test for bladder cancer.

“This test can stratify patients with haemeaturia (blood in the urine), who are at high risk of bladder cancer – reducing the number of unnecessary cystoscopies carried out on patients identified as ‘low risk’, significantly reducing healthcare costs and improving the waiting times for haematuria patients.”

For further information about the UK-China Oncology Congress, please email info@randoxbiosciences.com

 

 

 

 

 


Randox Antrim Show now open for entries

If you are looking for a day filled with all things country, there will be a fantastic display of award-winning majestic horses, clean cattle, woolly sheep, pink pigs and bleating goats to enjoy at this year’s Randox Antrim Show on Saturday 28 July at the picturesque Shane’s Castle.

Sponsors, stewards, members, supporters and local YFC members recently gathered to find out what’s new as entries were opened for this year’s event.

Donations

During the evening, the Antrim Agricultural Society donated £1,000 to the Chest, Heart and Stroke Association of Northern Ireland, in memory of the late George Robson Senior, past Patron of the Society.

Also, in memory of their father, George and Suzanne Robson presented the George Robson Memorial Cup to the Society.  The cup will be presented to the Show’s Champion Dorset.

James Crawford also presented a trophy this year; a shield for Gardener of the Year.

The sponsor’s reception was kindly supported by the Council and catered for by Kells & Connor and Lylehill YFCs.

New Bursary Recipient

Naomi McCullen from Straid YFC was revealed as being the lucky recipient of the inaugural Randox Antrim Show YFC bursary. Her role will see her travel to several shows across the country to compile a presentation of ideas to develop the show, helping ensure it continues to grow and appeal to both the rural and urban audience.

Finals and New Classes

Working Hunter Classes for ponies and horses make a welcome new addition to Antrim’s show Schedule this year.  Antrim is also a qualifier for the Bluegrass/NISA Clydesdale Championship 2018.  This is in addition to normal classes and the show-jumping section with a total prize fund of £2,250.

In the sheep section, Antrim will be hosting the Border Leicester’s National Show, and classes for the new breed, Suffolk Cheviot, have been added. Dutch Texel will also be exhibited for the first time in Northern Ireland under the ‘Any other breed’ classes.

In the cattle section, Antrim will host the Final of the Bank of Ireland/NISA Pedigree Junior Bull Championship and be a qualifier for the Linden Foods/NISA Pedigree Beef Heifer Championships.

For the fifth year, Antrim will host the NI Limousin Championships which will also incorporate the Young Limousin Breeders Anglo Irish Stock Judging Competition.

Home Industries has a new class this year – the Women’s Institute Team Competition – and the Show is a qualifier for the final of the County Antrim Show’s Chocolate Cake of the Year competition.

The exhilarating, crowd pleasing NI Sheep Shearers Association’s shearing competition once again returns. Its grandstand has the added bonus of giving you a chance for a rest while you watch the against-the-clock spectacle.

Speaking at the launch of Randox Antrim Show, Chairman Fred Duncan said;

“This year’s event will once again take place in Shanes Castle on Saturday 28th July thanks to the hard work of our directors, members and volunteers but also thanks to the much-needed support of many sponsors big and small, new and returning.  I’d like to give a special mention to Randox who’ve returned for a second year as our title sponsor; the Mayor of Antrim & Newtownabbey, Councillor Paul Michael for enabling our launch, and Lord O’Neill for access to the Castle’s beautiful grounds, which helps add to the family day out we annually put on for the benefit of those from both the rural and urban communities to enjoy.”

Representing the show’s title sponsor at the launch, Marc Coppez, Randox Health Business Development Manager, commented;

“Following a successful first year as sponsor of the Randox Antrim Show in 2017, we are delighted to be once again supporting one of Antrim and Newtownabbey’s most popular events. As a locally-headquartered company we’re very committed to our roots, and relish the opportunity to recognise the backing we have received over the years whilst simultaneously supporting the agricultural community. We are very much looking forward to the event in July, and to sharing our message with event attendees – that with the help of Randox Health, you can extend your life, to live healthier for longer.”

Some Family Fun Highlights

From creative crafts to calorific cakes, there will be lots of non-farm animal activities that will have wide appeal to attract spectators from both farming and non-farming communities.

New for 2018 is a Youth Busking Competition where 12-17 year olds who reside in the Council area, can busk during the afternoon with the chance of winning £250 for themselves and £100 for their school or youth group.  Email the Show Secretary before 20th July for details on how to register.

Northern Ireland’s very own celebrity chef Paula McIntyre returns with cookery demonstrations in the Festival of Food marquee as does last year’s successful introduction of dog agility displays, a petting zoo for kids and the ‘King & Queen of the Castle’ jiving competition.

The YFC County Games Competitions Day will also be held at Antrim with Tug-of-war, Tractor Handling, Gator Challenge and Slippery Football just to mention a few of the games.

Other popular spectacles on the day include the Children’s Pet Show and the varied displays of floral art, photography, jams, wine, eggs, baking, fruit, vegetables, handicraft, horticulture, baking, and arts and crafts projects from Primary Schools and Young Farmers’ Clubs.  There will also a range of side shows and attractions to keep kids of all ages amused, and many trade stands and stalls to browse.

Entries Open

A copy of the Show Schedule is available from the Show Secretary or can be downloaded from www.randoxantimshow.com

 Times and Prices

The action takes place on Saturday 28th July from 9am to 5pm. Admission to Randox Antrim Show is £10 per person and children under 16 years of age go free when accompanied by a paying adult. Car parking is also free.

For further information, contact Show Secretary, Patricia Pedlow by e-mailing secretary@antrimshow.com

 

 

 

 

 


Evidence Investigator | Adaptable, Efficient & Comprehensive

The Evidence Investigator is a compact, semi-automated benchtop analyser that offers efficient and comprehensive testing across a range of applications including clinical diagnostics, molecular, research, toxicology and food diagnostics.

Renowned for its versatility, robustness and effective reporting methods, the Evidence Investigator has been used in a wide range of laboratory settings for over 15 years. This highly advanced yet simple to use analyser has only one moving part, giving the user peace of mind.

The Evidence Investigator contains a host of innovative on-board data analysis features ensuring manual processes are kept to a minimum.

By utilising the same multiplex technology as the other Evidence Series analysers, the Evidence Investigator can process up to 44 results from a single sample, with a maximum throughput of up to 2376 tests per hour. Offering efficiency without compromising on accuracy, the Evidence Investigator is the perfect fit for medium throughput laboratories seeking maximum use of bench space.

 

Accurate and Robust

Like all the Evidence Series analysers, what sets it apart is technology. The Evidence Investigator is extremely well equipped to provide reliable results, while simultaneously robust enough to withstand frequent, heavy use.

Results are generated using a Charge Coupled Device (CCD) camera, which quantifies chemiluminescent light. This light measures the degree of binding between the patient sample and specific biochip bound ligands, generating highly accurate and reliable results.

Consolidation

The Evidence Investigator is the world’s first platform allowing consolidation of immunoassay and molecular diagnostics. This is achieved through utilising protein and DNA based biochips. By giving the user the ability to consolidate tests, the Evidence Investigator improves laboratory efficiency and reduces costs.

Advanced Reporting

The Evidence Investigator image processing software translates light signal generated from chemiluminescent reactions into analyte concentration. This removes the need for any manual processing of data.

Previously unreported tests can also be retrieved, so they can be tested retrospectively. This saves time, labour costs and reduces any reagents wastage. All data is then analysed on-board, removing issues related to human error and result manipulation.

About the Randox Evidence Series

The Evidence Series is set to revolutionise diagnostic testing forever. Offering unrivalled capabilities across all analysers, we truly believe that the Evidence Series range of immunoassay analysers can meet your diagnostic testing capabilities.

For more information on the Evidence Investigator, or any of the Evidence Series analysers, visit https://dev.randox.com/evidence-series/ or contact us evidenceseries@randox.com.

 

 

 

 

 

 

 


Randox Toxicology: The Next Wave in Drug Abuse

A letter published by The New England Journal of Medicine documented that officials from the Food and Drug Administration (FDA); Douglas C. Throckmorton, Scott Gottlieb and Janet Woodcock have warned that non-opioid painkillers could be at the forefront of the next wave of drug abuse.

The Centers for Disease Control and Prevention reported that over 42,000 deaths in the US were due to opioid abuse in 2016, with 40% of all opioid related deaths having involved prescription opioids. As a result, the FDA are encouraging doctors to prescribe alternative opioid drugs when possible and are developing new therapeutics to help people dealing with pain.

However, fears have been raised that curbing prescription opioid abuse could lead to opioid substitutes being used. Substances that are being closely watched include over the counter treatments; benzodiazepines and kratom.

Benzodiazepines

Benzodiazepines are minor tranquillisers used to treat anxiety and insomnia. The effects include sedation, suppressing fits and making the user feel calm and relaxed. When mixed with other depressant drugs like heroin or alcohol, benzodiazepines can cause short term memory loss and nasty withdrawal symptoms such as tremors, anxiety and vomiting. These tranquillisers come in tablet form which people may crush or melt to inject, making them extremely dangerous and sometimes fatal.

 

 

 

 

Kratom

The tropical tree known as kratom, grows in marshy areas around Asia and contains the active chemicals mitragynine, mitraphylline and 7-hydroxymitragynine. The effects of taking kratom include an opiate like sedation and a stimulated state of alertness, whilst higher doses can trigger severe nausea and vomiting. Heavy use of the drug can also cause constipation, darkening of the skin, insomnia, dry mouth and anorexia.

As the primary manufacturer of Biochip Array Technology, our cutting-edge multiplex testing capabilities offer rapid and accurate drug detection. Providing the most comprehensive drugs of abuse test menu across multiple forensic matrices, our multi-analyte testing platform allows toxicologists to achieve a complete immunoassay profile in the initial screening phase from a single sample and CVs are typically less than 10%.

With new designer drugs appearing all too frequently, it’s essential to react and create new tests. Our level of expertise in toxicology research and development allows us to do exactly that, evident through our NPS II panel which detects the latest designer drugs including Mitragynine. As new psychoactive substances are proliferating at an unprecedented rate the rapid evolution of adequate equipment remains vital.

Alongside our NPS II panel, Randox Toxicology provide the highest quality ELISAs available on the market including our exclusive mitragynine ELISA and results provide excellent correlation with confirmatory methods.

By adapting quickly to the ever-changing market influences and developing assays with optimum target compounds and excellent specificities for current and novel drug trends, Randox Toxicology continue to advance the future of toxicology and minimise laboratory workflow constraints.

For more information about our unrivalled toxicology test menu, email info@randoxtoxicology.com or visit www.randoxtoxicology.com

Did you know that cardiovascular disease is the most common cause of death in women? Cardiovascular disease, or CVD, accounts for 27% of all female deaths. That’s much higher than what is commonly thought to be the biggest killer of women – breast cancer. At Randox, we’re using our innovative technology to diagnose CVD cases as early as possible so appropriate treatment can be sought.

The Randox clinical product range offers a wide range of products to combat heart issues including the RX series extensive cardiac testing panel, reagents such as H-FABP, Adiponectin an TxB Cardio and an extensive cardiac QC range available in both liquid & lyophilised format.

You can find out more about how Randox is helping to diagnose women’s health issues, such as CVD, here.

What is CVD?

Cardiovascular disease (CVD) is a general terms for conditions that affect the heart and/or blood vessels. It is usually associated with the build-up of fatty deposits in the arteries and an increased risk of blood clots.

CVD is one of the main causes of death and disability in the UK but can often largely be prevented with a healthy lifestyle.

Types of CVD

Coronary heart disease

This occurs when the flow of oxygen-rich blood to the heart muscle is blocked or reduced

Stroke

A stroke is where the blood supply to part of the brain is cut off, which can cause brain damage and possibly death. A transient ischaemic attack (also called a TIA or “mini-stroke”) is similar, but the blood flow to the brain is only temporarily disrupted.

Causes of CVD

The exact cause of CVD isn’t clear, but there are lots risk factors that can increase your risk of getting it. The more risk factors you have, the greater your chances of developing CVD. Risk factors include:

  • High blood pressure
  • Smoking
  • High cholesterol
  • Diabetes
  • Inactivity
  • Being overweight or obese
  • Family history of CVD
  • Ethnic background

Preventing CVD

  • Stop smoking
  • Have a balanced diet
  • Exercise regularly
  • Maintain a healthy weight
  • Cut down alcohol consumption

How is Randox helping to detect CVD?

Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers many tests for the diagnosis and monitoring of cardiac diseases.

Cardiac Panel

Cholesterol CRP Full Range(0.3-160mg/l) Direct LDL Cholesterol sLDL
CK-MB CRP High Sensitivity Heart-Type Fatty Acid Binding Protein (H-FABP) Triglycerides
CK-NAC Digoxin Lipoprotein(a) TxB Cardio
CRP Direct HDL Cholesterol Myoglobin Adiponectin

 

Our world leading test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.

For more information visit: https://dev.randox.com/clinical-chemistry-analysers/

 

 

 


Women’s Health: Testing for CVD

Did you know that cardiovascular disease is the most common cause of death in women? Cardiovascular disease, or CVD, accounts for 27% of all female deaths. That’s much higher than what is commonly thought to be the biggest killer of women – breast cancer. At Randox, we’re using our innovative technology to diagnose CVD cases as early as possible so appropriate treatment can be sought.

The Randox clinical product range offers a wide range of products to combat heart issues including the RX series extensive cardiac testing panel, reagents such as H-FABP, Adiponectin an TxB Cardio and an extensive cardiac QC range available in both liquid & lyophilised format.

You can find out more about how Randox is helping to diagnose women’s health issues, such as CVD, here.

What is CVD?

Cardiovascular disease (CVD) is a general terms for conditions that affect the heart and/or blood vessels. It is usually associated with the build-up of fatty deposits in the arteries and an increased risk of blood clots.

CVD is one of the main causes of death and disability in the UK but can often largely be prevented with a healthy lifestyle.

Types of CVD

Coronary heart disease

This occurs when the flow of oxygen-rich blood to the heart muscle is blocked or reduced

Stroke

A stroke is where the blood supply to part of the brain is cut off, which can cause brain damage and possibly death. A transient ischaemic attack (also called a TIA or “mini-stroke”) is similar, but the blood flow to the brain is only temporarily disrupted.

Causes of CVD

The exact cause of CVD isn’t clear, but there are lots risk factors that can increase your risk of getting it. The more risk factors you have, the greater your chances of developing CVD. Risk factors include:

  • High blood pressure
  • Smoking
  • High cholesterol
  • Diabetes
  • Inactivity
  • Being overweight or obese
  • Family history of CVD
  • Ethnic background

Preventing CVD

  • Stop smoking
  • Have a balanced diet
  • Exercise regularly
  • Maintain a healthy weight
  • Cut down alcohol consumption

How is Randox helping to detect CVD?

Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers many tests for the diagnosis and monitoring of cardiac diseases.

Cardiac Panel

Cholesterol CRP Full Range(0.3-160mg/l) Direct LDL Cholesterol sLDL
CK-MB CRP High Sensitivity Heart-Type Fatty Acid Binding Protein (H-FABP) Triglycerides
CK-NAC Digoxin Lipoprotein(a) TxB Cardio
CRP Direct HDL Cholesterol Myoglobin Adiponectin

 

Our world leading test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.

For more information visit: https://dev.randox.com/clinical-chemistry-analysers/

Did you know that cardiovascular disease is the most common cause of death in women? Cardiovascular disease, or CVD, accounts for 27% of all female deaths. That’s much higher than what is commonly thought to be the biggest killer of women – breast cancer. At Randox, we’re using our innovative technology to diagnose CVD cases as early as possible so appropriate treatment can be sought.

The Randox clinical product range offers a wide range of products to combat heart issues including the RX series extensive cardiac testing panel, reagents such as H-FABP, Adiponectin an TxB Cardio and an extensive cardiac QC range available in both liquid & lyophilised format.

You can find out more about how Randox is helping to diagnose women’s health issues, such as CVD, here.

What is CVD?

Cardiovascular disease (CVD) is a general terms for conditions that affect the heart and/or blood vessels. It is usually associated with the build-up of fatty deposits in the arteries and an increased risk of blood clots.

CVD is one of the main causes of death and disability in the UK but can often largely be prevented with a healthy lifestyle.

Types of CVD

Coronary heart disease

This occurs when the flow of oxygen-rich blood to the heart muscle is blocked or reduced

Stroke

A stroke is where the blood supply to part of the brain is cut off, which can cause brain damage and possibly death. A transient ischaemic attack (also called a TIA or “mini-stroke”) is similar, but the blood flow to the brain is only temporarily disrupted.

Causes of CVD

The exact cause of CVD isn’t clear, but there are lots risk factors that can increase your risk of getting it. The more risk factors you have, the greater your chances of developing CVD. Risk factors include:

  • High blood pressure
  • Smoking
  • High cholesterol
  • Diabetes
  • Inactivity
  • Being overweight or obese
  • Family history of CVD
  • Ethnic background

Preventing CVD

  • Stop smoking
  • Have a balanced diet
  • Exercise regularly
  • Maintain a healthy weight
  • Cut down alcohol consumption

How is Randox helping to detect CVD?

Randox has developed the RX series of clinical chemistry analysers for superior semi-automated and fully automated testing. The RX series extensive dedicated test menu goes beyond routine testing and has many unique and high-performance tests available. Our range of tests covers many tests for the diagnosis and monitoring of cardiac diseases.

Cardiac Panel

Cholesterol CRP Full Range(0.3-160mg/l) Direct LDL Cholesterol sLDL
CK-MB CRP High Sensitivity Heart-Type Fatty Acid Binding Protein (H-FABP) Triglycerides
CK-NAC Digoxin Lipoprotein(a) TxB Cardio
CRP Direct HDL Cholesterol Myoglobin Adiponectin

 

Our world leading test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

The RX series clinical chemistry analysers provide laboratories with a robust and smart solution ensuring you maintain a consistent workflow and can provide accurate results first time, every time. Offering excellent customer support services, our trained engineers are on hand to work with you in preserving the continuity of your operations while maximising the potential of your RX series instrument.

For more information visit: https://dev.randox.com/clinical-chemistry-analysers/

 

 

 


Randox Food Diagnostics: Infiniplex Array for Milk

Drug residues in milk present major concern for farmers, dairy processors, cheese manufacturers, authorities and consumers due to the potential public health and industrial implications. Through the potential inappropriate antimicrobial use in animals producing product for human consumption, antibiotic-resistant organisms can enter the food supply or can spread to various components of the ecosystem. For consumer protection, regulatory limits have been set for the majority of compounds.

Randox Food Diagnostics provides screening technology to monitor the levels of these potentially harmful compounds including the Infiniplex for Milk Array available on the Evidence Investigator and Evidence Multistat analysers.

Using the Randox Food technology the user can identify 130 analytes from a 200µl sample of raw milk and follows this simple process to results:

  • Pipette the sample directly onto the MultiSTAT biochip
  • Insert into the Evidence MultiSTAT
  • Press Play and follow the on-screen prompts
  • Results appear on screen in under 20 minutes

Developed to provide an easy to use option for the user, the Infiniplex Array for Multistat can be used by anyone to ensure rapid on-site testing within the dairy industry.

The InfiniPlex test menu is 98% compliant with EU regulations and screens for additional contaminants including; antiparasitic, anti-inflammatories, non-steroidal and unauthorised substances from one sample of raw milk, creating a better end product for the processor and end user.

To find out more about InfiniPlex contact info@randoxfooddiagnostics.com

 

 

 

 

 


RTS: The Dangers of Psychoactive Substances

Psychoactive substances, formerly known as legal highs, are substances which produce the same or similar effects as many illegal drugs such as cannabis, ecstasy and cocaine. With many psychoactive substances it is extremely difficult to know their potency and therefore how they will affect the user.

They are divided into four main groups:

Sedatives – Cause reduced concentration and slowing of reactions, leading user to feel physically unsteady and lethargic.

Hallucinogenic – These substances cause psychedelic reactions which can lead the user to act erratically, putting their own safety at risk.

Stimulants – Substance temporarily causes increase in alertness and energy, while also putting a strain on the nervous system.

Synthetic Cannabinoids – Large doses can lead to life-threatening intoxication. Also effects the central nervous system causing seizures, high blood pressure, rapid heart rate and increased body temperature.

Incidents

Last month two men were arrested and jailed for four and a half years for selling psychoactive substances. The offences were committed in Scotland and eight of the men’s customers needed hospital treatment after taking the substances.

Free samples and loyalty cards were used by the men selling the psychoactive substances and two users were left in comas after taking a substance known as Psyclone. Court was told that the shops took in as much as £2,500 in sales every day.

The sister of a man who died from taking psychoactive substances said it changed her brother “mentally and physically.” BBC Scotland was told that he started dabbling with psychoactive substances because he believed they were legal. “Some of them were a substitute of heroin, others to mimic the effects of cannabis. He became very withdrawn with the family and just wanted to stay away.”

 

Randox Testing Services

At Randox Testing Services we reacted to the issues caused by psychoactive substances by releasing the world’s first Synthetic Cannabinoids (JWH/AM) and ‘Bath Salt’s’ (MPDV) tests in 2012. This enables companies to test for popular types of psychoactive substances and showed that it was possible to detect these substances.

However as new psychoactive substances emerged new tests also had to be created and next generation Synthetic Cannabinoids tests (UR144 and JWH250) were released in 2013. These tests represented a milestone in the fight against the highly dangerous psychoactive substances and provided a way for laboratories and companies to stay on top of the developing drug trends.

Psychoactive Substances we currently screen for;

 

 

 

 

 

 

Today, in the endless pursuit of creating innovative tests for new and emerging psychoactive substances, our expertise sets us apart from the rest of the industry. We will continue to develop our test menus and grow our range of tests.

For more information contact us today at testingservices@randox.com.

 

 

 

 

 


We Are Randox | Christopher McNally climbs the career leader from Placement to PhD

The name Christopher McNally may be one that you already recognise. In 2016 he earned 1st place in the Science category of the Randox Pinnacle Placement Awards, having caught the attention of Senior Management for his pioneering work developing a new diagnostic for pancreatic cancer.

Fast-forward two years and Christopher is now back at Randox as a PhD student, conducting research in prostate cancer as part of the recently-announced Randox-Ulster University PhD Academy.

We sat down with Chris to hear all about his revolutionary prostate cancer project, what motivated him to sign up to our PhD Academy and what it’s like to be back in the place where his scientific career began.

Here’s Chris’ story.

I came into Randox when I was just 19 years old for my third year at university as part of the company’s year-long placement programme. It was a great way to truly experience a working laboratory outside of the classroom and really cemented my desire to work in biomedical science.  

I was lucky enough to be placed in the company’s Donegal branch, Randox Teoranta, which is close to where I grew up in Gartan, and offered me the opportunity to carry out ground-breaking medical research surrounded by my home of Donegal.

I would highly recommend the opportunity to perform an industrial placement to anyone. It helps you to prepare for what comes after university, develops your skills in the area in which you are interested, and refines your laboratory techniques. I was delighted to hear I won in the Science Category of the Randox Pinnacle Placement Awards during my time there as well, and this really inspired a confidence in me that I had become a talented scientist even before I graduated.

When I completed my fourth year of studies at Ulster University, I graduated with a degree in Biomedical Science and Professional Practice, and returned to work for Randox. The traits and qualities I learned during my placement had subsequently brought me to post-graduate employment, and I was thrilled. I was lucky enough to be able to walk straight back into the lab knowing exactly what to do and how to do it.

Despite becoming employed within Randox straight out of university however, I had this feeling that I was not finished with regards to academic study. I knew I wanted to do more, to perform more research. So, when I heard about the Randox-Ulster University PhD Academy I really was intrigued. It was the perfect platform to further my studies and be able to give more to the scientific community.

When choosing the area of research for my PhD I was keen to hear more about a collaborative prostate cancer project led by two of Northern Ireland’s leading cancer researchers Dr Mark Ruddock (Randox) and Dr Declan McKenna (Ulster University). From my time at university and my time spent at Randox, I thought I could bring my experience and knowledge in cancer research into this project, so I thought, let’s go for it. 

Ultimately, the project involves looking at prostate cancer patients as well as patients who have other non-serious prostate conditions, and recognising any potential differences in the two. We can then develop a clinical diagnostic test that can identify the men at the highest risk of prostate cancer and stratify the patients accordingly.

The earlier we can do this, the quicker a patient can be treated, or not treated as the case may be. Overdiagnosis is a significant problem in prostate cancer care and many men, who do not have prostate cancer, but present with prostate cancer-like symptoms, unfortunately go through invasive, uncomfortable and most importantly, unnecessary procedures.

This work therefore has real potential to improve the management of prostate cancer, which is currently the most common cancer in males within the UK. It’s a very rewarding field to be working in and I thoroughly enjoy the work I’m doing knowing that it will have a real-life impact on many men. I’m very proud to be able to say that my PhD research will really make a difference and I now know for certain that I will continue working in cancer research after my project is complete.

Knowing that I’m helping to improve the quality of patient’s lives brings a great deal of satisfaction that few jobs can replicate and I’m excited to see what the next three years will bring.

We’re very proud of Christopher and the amazing work he is doing in prostate cancer research, and are delighted that he has made the decision to join the Randox-Ulster University PhD Academy.

For more We Are Randox stories about our amazing colleagues, make sure to follow us on Facebook, Instagram and Twitter and follow the hashtag #WeAreRandox.

For current vacancies in our team, visit careers.randox.com

To find out more about the Randox-Ulster University PhD Academy, please email randoxpr@randox.com

 

 

 

 

 


RCLS – Tackling the Increase of Gonorrhoea and Syphilis

A report published by Public Health England (PHE) reveals that there was 7,137 diagnoses of syphilis reported in 2017, a 20% increase compared to 2016 and 44,676 diagnoses of gonorrhoea reported in 2017, a 22% increase compared to 2016.1

Overall, there were 422,147 diagnoses of sexually transmitted infections (STIs) in England during 2017.

To help with the increase of STI testing, Randox Clinical Laboratory Services offer a multiplex Sexually Transmitted Infection (STI) test kit allowing your clinic, laboratory or GP practice to outsource sample STI testing.

Our STI array is the broadest IVD multiplex array on the market simultaneously detecting 10 infections due to our patented and intelligent Biochip Array Technology which utilises multiplex testing methodology in a rapid and accurate format. These 10 bacterial, viral and protozoan infections consist of:

·        Chlamydia ·        Trichomonas Vaginalis
·        Gonorrhoea ·        Mycoplasma Hominis
·        Syphilis ·        Mycoplasma Genitalium
·        Herpes Simplex 1 ·        Ureaplasma Urealyticum
·        Herpes Simplex 2 ·        Chancroid

 

The type of sample which should be sent to our Randox Clinical Laboratory Service lab is determined by the visibility of the patient’s symptoms.

Non-visible symptoms – urine sample required

Visible symptoms – swab sample required

The process of sending samples to RCLS is simple and easy to follow. Our project management teams incorporate a wealth of knowledge and are available accordingly, providing support and guidance. This enables support to be available from your initial enquiry through to the shipment of the samples. As a result we are always delivering to your project aims and timelines.

RCLS currently has four state of the art, fully functional ISO12025 accredited laboratories across the UK. They are situated in Liverpool, London and two in Northern Ireland, Hollywood and Randox Science Park in Antrim.

Overall, by utilising Randox Clinical Laboratory Services you can save your laboratory time and money. Due to our multiplex panels we offer a cost effective, labour saving and time reducing solutions for your STI testing. Providing your laboratory with the best solution to outsource your samples.

Contact us at info@rcls.com to find out more information about RCLS and our STI testing service.

Sources
1 – Public Health England

 

 

 


Clinical Laboratory Survey